Atrial Fibrillation and Obesity. An Association of Increasing Importance

Journal of the American College of Cardiology

Volumn 55, Issue 21, 2010, Pages 2328-2329

  Dagres, Nikolaos ^a   Anastasiou Nana, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

atrial fibrillation; obesity

Indexed keywords

BODY MASS; CARDIOVASCULAR RISK; CATHETER ABLATION; DISEASE ASSOCIATION; EDITORIAL; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL RECORD; OBESITY; PRIORITY JOURNAL; QUESTIONNAIRE; WEIGHT CONTROL;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BODY MASS INDEX; CATHETER ABLATION; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; OBESITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 77952138075     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.045     Document Type: Editorial

References (13)

1. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006) 119-125
2. Khoo C.W., and Lip G.Y. Burden of atrial fibrillation. Curr Med Res Opin 25 (2009) 1261-1263
3. Stewart S.T., Cutler D.M., and Rosen A.B. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med 361 (2009) 2252-2260
4. Stritzke J., Markus M.R., Duderstadt S., et al. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging: the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. J Am Coll Cardiol 54 (2009) 1982-1989
5. Wang T.J., Parise H., Levy D., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004) 2471-2477
6. Dublin S., French B., Glazer N.L., et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 166 (2006) 2322-2328
7. Tedrow U.B., Conen D., Ridker P.M., et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (Women's Health Study). J Am Coll Cardiol 55 (2010) 2319-2327
8. Fetsch T., Bauer P., Engberding R., et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 25 (2004) 1385-1394
9. Israel C.W., Grönefeld G., Ehrlich J.R., Li Y.G., and Hohnloser S.H. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43 (2004) 47-52
10. Kirchhof P., Auricchio A., Bax J., et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 9 (2007) 1006-1023
11. Rienstra M., van Veldhuisen D.J., Hagens V.E., et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation. Data of the Rate Control versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 46 (2005) 1298-1306
12. Dagres N., Nieuwlaat R., Vardas P.E., et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 49 (2007) 572-577
13. Rosengren A., Hauptman P.J., Lappas G., Olsson L., Wilhelmsen L., and Swedberg K. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 30 (2009) 1113-1120